The once-daily human GLP-1 analog, liraglutide, reduces olanzapine-induced weight gain and glucose intolerance
Month-to-month billing (no multi-month commitment required)
In addition, despite continuous discussions about affordability, insurers are progressively expanding reimbursement coverage, increasing the accessibility of these treatments
By combining advanced pharmaceutical options with a supportive, patient-centered environment, we help you transition from the preparation phase to active weight loss with complete peace of mind
These GLP-1 drugs are specifically indicated for weight loss
I generally do not advise patients to discontinue abruptly, not only because of the increased risk of rebound, but also because it can cause uncontrolled sugar spikes initially, Dr